MariMed Inc.
MRMD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $158 | $149 | $134 | $121 |
| % Growth | 6.3% | 10.9% | 10.3% | – |
| Cost of Goods Sold | $95 | $83 | $70 | $55 |
| Gross Profit | $63 | $66 | $64 | $66 |
| % Margin | 39.8% | 44.4% | 47.7% | 54.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $53 | $45 | $35 | $36 |
| SG&A Expenses | $59 | $51 | $39 | $38 |
| Sales & Mktg Exp. | $7 | $6 | $4 | $2 |
| Other Operating Expenses | $1 | $0 | -$0 | $0 |
| Operating Expenses | $60 | $52 | $39 | $38 |
| Operating Income | $3 | $15 | $20 | $27 |
| % Margin | 1.8% | 10.1% | 15.2% | 22.1% |
| Other Income/Exp. Net | -$7 | -$22 | -$1 | -$3 |
| Pre-Tax Income | -$4 | -$7 | $20 | $24 |
| Tax Expense | $8 | $9 | $6 | $16 |
| Net Income | -$12 | -$16 | $13 | $7 |
| % Margin | -7.7% | -10.8% | 10% | 5.9% |
| EPS | -0.032 | -0.044 | 0.04 | 0.022 |
| % Growth | 27.2% | -210.5% | 80.5% | – |
| EPS Diluted | -0.032 | -0.044 | 0.035 | 0.019 |
| Weighted Avg Shares Out | 379 | 363 | 338 | 326 |
| Weighted Avg Shares Out Dil | 379 | 363 | 380 | 372 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $0 |
| Interest Expense | $7 | $9 | $2 | $2 |
| Depreciation & Amortization | $11 | $9 | $5 | $3 |
| EBITDA | $14 | $11 | $26 | $29 |
| % Margin | 8.8% | 7.5% | 19.3% | 23.8% |